This study was designed to test whether altered aldosterone-related sodium handling leads to salt-sensitive blood pressure in diabetes and thus may exaggerate end-organ damage. Zucker diabetic fatty (ZDF) rats, a model of type 2 diabetes, and Zucker lean (ZL) rats, as euglycemic controls, were divided into groups receiving normal (0.28%) (ZDF+N, ZL+N) and high-salt (5.5%) diets (ZDF+S, ZL+S) for 10 weeks. Renal mRNA expression of serum-and glucocorticoid-inducible kinase 1 (SGK1) and sodium transporters (for example, the epithelial sodium channel-a, ENaCa) were measured by quantitative reverse transcriptase-PCR. Vascular hypertrophy (media-to-lumen ratio, M/L) in mesenteric resistance arteries was assessed using a pressurized myograph. Systolic blood pressure (SBP) was significantly higher in ZDF+S vs. ZDF+N (146±2 vs. 133±3 mm Hg; Po0.05), whereas there was no difference between ZL+S and ZL+N (151±3 vs. 147±3 mm Hg). Plasma sodium concentration was higher in ZDF+S vs. ZDF+N, whereas there was no difference between ZL+S and ZL+N. Plasma aldosterone concentration (PAC) was higher in ZDF+N as compared with ZL+N (191 ± 23 vs. 95 ± 35 pg ml À1 ; Po0.05). PAC decreased to zero in ZL+S, which was not the case in ZDF+S (0±0 vs. 37±2 pg ml À1 ). Salt loading decreased the mRNA expression of SGK1 in euglycemic controls (ZL+S 0.58 ± 0.2 vs. ZL+N 1.05 ± 0.05; P¼0.05), whereas it significantly increased SGK1 expression in diabetic rats (ZDF+S 1.75 ± 0.15 vs. ZDF+N 0.92 ± 0.07; Po0.01). ENaCa mRNA expression paralleled these changes. The M/L of mesenteric resistance arteries was not different between ZDF+N and ZL+N. High salt significantly increased the M/L in ZDF+S vs. ZDF+N, but not in ZL+S vs. ZL+N. Systolic blood pressure in this model of type 2 diabetes mellitus is salt sensitive, leading to marked vascular remodeling. The underlying pathophysiological mechanism may be inappropriately high levels of aldosterone and up-regulation of SGK1-dependent renal sodium transport by ENaCa, leading to net increased sodium retention.
INTRODUCTION
Diabetes mellitus and arterial hypertension are important causes of vascular damage. The combination of the two places the patient at particularly high cardiovascular risk. 1 Both diabetes mellitus and hypertension are part of the metabolic syndrome. However, it is not fully understood how they influence each other. In this context, some studies suggest that blood pressure (BP) in diabetes mellitus is salt sensitive. [2] [3] [4] Recently, a study in 1906 Chinese participants suggested that the metabolic syndrome enhances the BP response to sodium intake. 5 However, the underlying pathological mechanisms remain to be elucidated. Aldosterone is known to have a major function in the regulation of salt balance, and we have previously shown that Zucker diabetic fatty (ZDF) rats, as a model for type 2 diabetes mellitus, display hyporeninemic hyperaldosteronism. 6 Induction of the serumand glucocorticoid-induced kinase 1 (SGK1), an aldosterone target gene, is a primary event in the antinatriuretic effect of aldosterone. 7, 8 The activation of SGK1 has been reported to be carried out mainly by phosphoinositide-dependent kinase, a downstream regulator of phosphoinositide 3-kinase. 9, 10 One of the known actions of SGK1 is to activate the a-subunit of the epithelial Na + channel (ENaC), a key regulator of Na + transport in the kidney and other epithelia, resulting in enhanced sodium reabsorption in the cortical collecting tubules. 8 Furthermore, SGK1 regulates the plasma membrane abundance of ENaC by interaction with and phosphorylation of Nedd4-2, a downregulator of ENaC, leading to reduced interaction between ENaC and Nedd4-2 and thus elevated ENaC cell surface expression. 11, 12 Thus, naturally occurring Nedd4-2 isoforms differentially associate with ENaC, regulating its activity. 13 Besides ENaC, the thiazide-sensitive NaCl cotransporter (NCC) is activated by aldosterone, also through a SGK1-dependent pathway. 14 In addition to aldosterone, hyperinsulinemia has been shown to phosphorylate SGK1 by a phosphoinositide 3-kinase pathway and may therefore lead to sodium reabsorption. [15] [16] [17] [18] Given the elevated aldosterone and insulin levels in ZDF rats, we hypothesized that renal SGK1 expression would be increased in experimental type 2 diabetes mellitus, leading to salt-sensitive hypertension and early remodeling of resistance arteries. To address this hypothesis, we studied ZDF rats on normal-and high-salt diets. ZDF rats have a mutation in the leptin receptor-encoding gene that impairs the ability of leptin to suppress food intake, making them a useful model of type 2 diabetes and the metabolic syndrome. Their Zucker lean (ZL) littermates on normal-and high-salt diets served as controls. All animals were characterized with respect to systolic blood pressure (SBP), renal sodium excretion, aldosterone, renal SGK1, the expression of ENaC and other sodium cotransporters (for example, NCC) and vascular remodeling. Most complications of diabetes mellitus and arterial hypertension are related to vascular damage. Moreover, remodeling of small resistance arteries has been suggested to be the earliest form of end-organ damage in mild essential hypertension. 19 For small resistance arteries, the media-to-lumen ratio, a measure of vascular remodeling, has been shown to be a strong predictor of cardiovascular end points. 20 Thus, vascular remodeling was studied in small resistance arteries in this experiment using a small vessel myograph.
METHODS

Animal experiments
The study was approved by the local committee on animal research and adhered to the 'Guide for the Care and Use of Laboratory Animals' published by the US National Institutes of Health. Eighteen male ZDF rats (fa/fa) (Charles River Laboratories, Wilmington, MA, USA) with a genetically induced form of type 2 diabetes, including severe hyperglycemia, and 18 normoglycemic ZL controls (Charles River Laboratories) were studied from age 14 weeks to 25 weeks. Rats were fed Purina 5008 rat chow (Charles River Laboratories) containing 23% protein, 6.5% fat, 58.5% carbohydrates, 4% fiber and 8% ash. They received tap water ad libitum. Rats were individually housed on a 12-h dark/12-h light cycle. At 15 weeks, rats were divided into four groups: ZDF rats receiving normal-salt diet (0.28% NaCl) (n¼9) (ZDF+N), ZDF rats receiving high-salt diet (5.5% NaCl in chow) (n¼9) (ZDF+S), ZL rats receiving normal-salt diet (0.28% NaCl) (n¼9) (ZL+N) and ZL rats receiving high-salt diet (5.5% NaCl in chow) (n¼9) (ZL+S). Rats were housed in metabolic cages at weeks 13, 15, 19 and 24 to assess 24-h excretion of sodium. Blood glucose was measured weekly from an incision in the tail vein (Accu-Chek Sensor, Roche, Mannheim, Germany). SBP and heart rate were measured weekly by the tail cuff method using an automated cuff inflator-pulse system (W+W electronic AG, BPrecorder No. 8005, Basel, Switzerland). At the end of the experiment, animals were killed and the mesenteric vasculature dissected. One segment was used for preparation of small arteries. Kidneys were removed, weighed and immediately snap-frozen in liquid nitrogen and stored at À80 1C for further mRNA and protein analysis.
Preparation and study of small arteries
A third-order branch of the mesenteric artery was carefully dissected and mounted on a pressurized myograph (111P, Danish Myo Technology, Aarhus, Denmark). Perfusion was performed using oxygenated 37 1C Krebs solution (95% O 2 , 5% CO 2 ) pH 7.4 containing (mmol l À1 ): NaCl (118), KH 2 PO 4 (1.18), KCl (4.7), MgSO 4 (1.18), CaCl 2 (2.5), D-glucose (5.5), NAHCO 3 (25) and EDTA (0.026). Vessels were equilibrated under a constant pressure of 45 mm Hg. The viability of the vessels was tested with a single dose of norepinephrine (10 À5 mol l À1 ). After precontraction with 10 À5 mol l À1 norepinephrine, endothelium-dependent relaxation was assessed with acetylcholine. Vascular morphology was assessed under resting conditions at three different points along the vessel. The growth index was calculated as (CSA h ÀC-SA n )/CSA n , where CSA n and CSA h are the medial cross-sectional areas of normal-salt and high-salt vessels, respectively.
Measurements in plasma and urine
Plasma aldosterone concentration and plasma renin activity were measured using commercially available kits (DiaSorin, Dietzenbach, Germany) according to the manufacturer's instructions and as described elsewhere. 21 The sampling was performed on ice. Plasma and urinary sodium were measured using a sodium-sensitive electrode (Advia 1800, Bayer Healthcare, Leverkusen, Germany). Plasma insulin levels were measured using a commercially available Insulin Elisa (Biocat GmbH, Heidelberg, Germany).
RNA isolation, reverse transcription and real-time PCR in rat specimens
After homogenization of frozen tissue sections in peqGOLD TriFast (Peqlab, Erlangen, Germany), total RNA was extracted according to the manufacturer's directions, with additional DNase digestion to remove all traces of genomic DNA.
Total RNA was reverse transcribed into complementary DNA according to standard protocols, as previously described. 22 In brief, complementary DNA probes were synthesized in 20-ml reaction volume containing 1 mg total RNA, 0.5 mg oligo(dT) primer (Sigma-Aldrich, Munich, Germany), 40 U RNasin (Promega, Mannheim, Germany), 0.5 mM dNTP (Amersham, Freiburg, Germany), 4 ml 5Â transcription buffer and 200 U Moloney murine leukemia virus reverse transcriptase (Invitrogen, Karlsruhe, Germany) for 1 h at 37 1C. In parallel, no-reverse transcriptase and no-template controls were performed. Real-time quantitative reverse transcriptase-PCR was performed on an ABI PRISM 7900 detection system (Applied Biosystems, Darmstadt, Germany) using a QuantiTect SYBR Green PCR Kit (Qiagen, Hilden, Germany). Glyceraldehyde-3-phosphate dehydrogenase was used as reference gene. All water controls were negative for target and glyceraldehyde-3-phosphate dehydrogenase. Data were analyzed using SDS 2.2.2 software (Applied Biosystems). Primers are given in Table 1 .
Western blot
SGK1 protein expression was examined in four representatives of each group by western blot analysis. After homogenization of frozen kidneys in peqGOLD TriFast (Peqlab Biotechnologies, Erlangen, Germany), total protein was extracted according to the manufacturer's directions. Protein concentrations were determined in duplicate with the method of Pierce. A bicinchoninic acid and copper sulfate mixture (200 ml; 50:1) (Sigma-Aldrich) was combined with 10 ml of the protein sample and incubated for 1 h at room temperature. Absorption was measured at 560 nm. For western blot analysis, 25 mg total protein was boiled with Laemmli buffer (Bio-Rad, Munich, Germany) at 95 1C for 5 min, subjected to 12% SDS-polyacrylamide gel electrophoresis and then Table 1 Primer sequences for renal mRNA analysis
Salt-sensitive blood pressure in diabetes mellitus M Resch et al transferred to nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) by semidry blotting, as described before. 22 Membranes were blocked with Tris-buffered saline with 0.1% Tween-20 (TBST) containing 5% non-fat dry milk for 90 min and incubated with the primary antibody (rabbit anti-SGK1 0.5 mg ml À1 , Upstate-Millipore, Lake Placid, NY, USA) overnight at 4 1C.
A horseradish peroxidase-conjugated secondary antibody was used to detect immunoreactive bands using the enhanced chemiluminescence western blotting detection system (Amersham Bioscience, Buckinghamshire, UK). Membranes were exposed to Hyperfilm (Amersham Bioscience). Afterwards, nitrocellulose membranes were stripped, washed and blocked with TBST containing 5% non-fat dry milk for 90 min. Detection was performed with a goat anti-b-actin antibody (1:1000, Santa Cruz, Santa Cruz, CA, USA; overnight at 4 1C) and a donkey anti-goat secondary antibody (1:2000, Santa Cruz; 1 h at room temperature) coupled to peroxidase and enhanced chemiluminescence.
Statistical analysis
Data are presented as mean±s.e.m. For blood glucose levels and SBP levels, mean values throughout active treatment were calculated for each animal.
Groups were compared using one-way analysis of variance. Post hoc testing was performed using Fisher's least significant difference test. A P-value o0.05 was considered significant.
RESULTS
Animal data
Body weight was significantly lower in ZL rats compared with ZDF rats at the start of the study. Over time, ZL rats continued to grow, resulting in a nonsignificant difference by the end of the study (Table 2 ). Blood glucose was normal in all ZL rats, with no difference between the high-and normal-salt diets. ZDF rats displayed significantly elevated blood glucose levels throughout the study. Interestingly, blood glucose levels were significantly lower in ZDF+S rats as compared with ZDF+N rats on the normal diet (Figure 1 ). Confirming previous studies, SBP was lower in ZDF rats at the start of the treatment. Although salt loading significantly increased SBP in ZDF rats (Figure 2) , it did not significantly change BP in normoglycemic ZL rats. There were no significant differences in heart rate throughout the study or in hematocrit at the end of the experiment (Table 2) .
Plasma and urinary analysis Serum sodium concentrations paralleled differences in mean SBP between the groups (Figure 3 ). Urinary volume was significantly higher in ZDF rats as compared with ZL rats. The high-salt diet significantly increased urinary volume in ZDF and ZL rats ( Table 2 ).
The 24-h urinary sodium excretion was significantly increased under the high-salt diet and was higher in ZDF rats as compared with ZL rats. However, ZDF rats ate more, so estimated salt uptake by chow consumption was also higher in ZDF rats (Table 2) . Plasma aldosterone concentration was significantly higher in ZDF rats as compared with controls (Table 2) . In ZL rats, the high-salt diet reduced plasma aldosterone levels to zero. In ZDF rats, the high-salt diet also significantly reduced plasma aldosterone concentration, but not to zero. Plasma renin activity was lower in ZDF rats, confirming a lowrenin hyperaldosteronism in these animals. Salt loading significantly reduced plasma renin activity in ZL and ZDF rats (Table 2) . Plasma insulin levels were higher in ZDF rats as compared with ZL rats, but at this age of the animals, the differences were not statistically different ( Table 2) .
Structure of small resistance mesenteric arteries Thickness of the media was not different between ZL and ZDF rats. The high-salt diet did not significantly alter media thickness in normoglycemic ZL rats. However, the high-salt diet dramatically increased media thickness in ZDF rats (Figure 4c ). There were no significant differences in lumen diameter between the groups (Figure 4d ). However, lumen diameter tended to be lower in salt- Figure 1 Serum glucose levels (mg per 100 ml) throughout the study period. Mean differences during treatment period: analysis of variance Po0.001, post hoc testing: ***Po0.001. Zucker lean (ZL)+N: ZL on normal diet; ZL+S: ZL on high-salt diet; Zucker diabetic fatty (ZDF)+N: ZDF on normal diet; ZDF+S: ZDF on high-salt diet.
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M Resch et al treated ZDF rats, resulting in even more pronounced changes in the media-to-lumen ratio (Figure 4a) . The cross-sectional area tended to be higher in ZDF rats and increased with salt loading. However, these differences were not statistically significant (Figure 4b ). The calculated growth index was identical for ZL and ZDF rats under salt treatment (33% in both salt-loaded ZDF and salt-loaded ZL rats). This indicates marked inward vascular remodeling in salt-treated ZDF rats.
SGK1 and SGK1-dependent epithelial sodium transporter mRNA expression In total kidney homogenates, mRNA expression levels of SGK1 were not significantly different between ZL+N and ZDF+N rats. As expected, mRNA levels were significantly decreased in normoglycemic ZL+S rats. In contrast, mRNA levels were significantly increased in diabetic ZDF+S rats (Figure 5a ). mRNA levels of the SGK1-dependent ENaCa sodium channel paralleled the levels of SGK1 mRNA (Table 3) . There was no evident regulation of the renal mRNA expression of ENaCb or ENaCg.
Confirming the mRNA data, we found a tremendous downregulation of SGK1 protein in ZL rats with high-salt treatment, which was not the case in ZDF rats (Figure 5b ).
Focusing on other renal sodium transporters (NCC, NKCC2, NHE3), we also found that NCC mRNA expression was significantly downregulated in ZL+S rats. In ZDF+N rats, NCC mRNA expression was lower than in ZL+N, but was not downregulated under high-salt treatment. A significant downregulation of NHE3 could only be found in ZDF+S rats, whereas no significant difference in comparison with ZL+N rats was found in the other groups (ZL+S, ZDF+N). We observed no effect on NKCC2 mRNA expression (Table 3) .
DISCUSSION
In this study, we show that BP is salt sensitive in the ZDF rat model of type 2 diabetes mellitus. We also demonstrate that this salt sensitivity has a substantial impact on vascular remodeling in small resistance arteries, as an early form of end-organ damage. Specifically, the media-to-lumen quotient, which was increased by 60% under salt loading only in diabetic ZDF animals, has been shown to be a strong predictor of cardiovascular end points. 20 Molecular analysis of the rat kidneys also showed dysregulation of ENaC, perhaps leading to the observed salt sensitivity.
There is an ongoing debate about the causes of hypertension in the metabolic syndrome. In our study, the plasma sodium concentrations paralleled the mean SBP changes, suggesting that the BP changes are due to aldosterone-mediated sodium retention. First, we showed that aldosterone levels were elevated in ZDF rats, and second, we found that under high-salt treatment, aldosterone levels were significantly reduced, but not to zero, which was the case in salt-loaded normoglycemic controls. Thus, the remaining aldosterone level in the saltloaded ZDF rats may still have been pathologically high and thus may have caused sodium retention and promoted deleterious actions in combination with the high-salt status of these animals. Consistent with this hypothesis, in another study, aldosterone mainly induced end-organ damage in settings of high-salt loading. 23 These findings may explain why diabetic ZDF rats under normal-salt conditions do not display vascular remodeling. It has been suggested that adipocytes produce aldosterone-releasing factors. 24 It is intriguing to assume such a mechanism because plasma renin activity is reduced in ZDF rats. Moreover, it is suggested that aldosterone-releasing factor-induced aldosterone release is not suppressed by salt loading, which may explain why plasma aldosterone levels were not reduced to zero in ZDF rats on a high-salt diet. Salt-sensitive blood pressure in diabetes mellitus M Resch et al
Another important finding of our study is that SGK1 was differentially regulated in kidneys of diabetic rats as compared with normoglycemic controls. SGK1 activates and regulates the ENaC, which is the rate-limiting channel for sodium retention. 25 SGK1 is known to be regulated by aldosterone and insulin. 26 Under physiological conditions, a high-salt diet reduces aldosterone levels, thereby reducing SGK1 expression. Consequently, plasma sodium concentrations and BP are kept relatively stable, as seen in normoglycemic ZL rats. However, in diabetic ZDF rats, SGK1 expression was pathologically upregulated under high-salt conditions, which was paralleled by ENaCa expression. Even at the protein level, the high-salt diet was not able to suppress SGK1 expression in ZDF rats. In addition, NCC mRNA was downregulated under high-salt conditions in ZL rats but not in ZDF rats. The fact that, in contrast to ENaC, NCC was only downregulated in ZL rats but not upregulated in ZDF rats under high-salt conditions might be due to differences in gene regulation. Thus, NCC expression may depend on both aldosterone and renin/angiotensin II. Interestingly, a recent study showed a similar gene expression pattern in another model of salt-sensitive hypertension. SGK1 expression on a high-salt diet was downregulated Salt-sensitive blood pressure in diabetes mellitus M Resch et al in Dahl salt-resistant rats but upregulated in Dahl salt-sensitive rats, a finding that was also paralleled by ENaC mRNA expression levels. 27 It was previously demonstrated by the same group that ENaC and SGK1 are pathologically altered by aldosterone in Dahl salt-sensitive rats. 28 Therefore, it is possible that abnormal regulation of SGK1 by aldosterone may also contribute to salt-sensitive BP in ZDF rats. Recently, a nuclear repressor complex (Dot1a) and its influence on SGK1 and ENaC were described. 29, 30 Besides the impact of other pathways, such as that involving Dot1a, the localization of the examined sodium transporter may also account for our results. In contrast to ENaC and NCC, which are both part of the aldosteronesensitive distal nephron, NKCC2 is mainly located in the thick ascending limb of Henle's loop, and microdissection studies have detected NHE3 in the thick ascending limbs and the thin descending limbs, but not in the collecting duct. 31 In our model, hyperinsulinemia may display another mechanism by which SGK1 is activated in ZDF rats: by phosphoinositide 3-kinase. In our experiment, SGK1 levels were not different in ZL and ZDF rats on the normal diet. Also, the insulin levels, with exhaustion of b-cell function, were only slightly elevated at this late stage of diabetes. Interestingly, in our experiment, blood glucose levels were lower in salt-loaded ZDF rats as compared with ZDF rats on the normal-salt diet. This low glucose level may be explained by elevated SGK1 expression on the high-salt diet. A study on SGK1-knockout mice and their wild-type littermates, which were not diabetic, suggested that high salt decreases SGK1 abundance and thus decreases SGK1-dependent cellular glucose uptake. 32 Thus, the abnormal upregulation of SGK1 in diabetic animals under high-salt conditions in our study may explain the enhanced glucose uptake into skeletal muscle and the reduced blood glucose levels under high-salt conditions. Moreover, a potential role for SGK1 in renal tubular glucose transport in diabetic kidneys was recently illustrated by Ackermann et al. 33 In this study, we showed that BP in diabetic ZDF rats is salt sensitive and leads to marked vascular remodeling only on a high-salt diet. Low-renin hyperaldosteronism and altered regulation of ENaCa, a SGK1-dependent renal sodium transporter, may be important for altered sodium handling and thus for the salt sensitivity of this model. 
